Health Program for Breast Cancer Survivors
Trial Summary
What is the purpose of this trial?
This is a pilot study testing multi-disciplinary health behavior intervention in breast cancer survivors who have been treated at Zuckerberg San Francisco General (ZSFG).
Do I need to stop my current medications for the trial?
The trial information does not specify whether you need to stop taking your current medications.
What data supports the effectiveness of the treatment HEART-ACT for breast cancer survivors?
Research shows that interventions using wearable activity trackers and health coaching can help breast cancer survivors increase physical activity and reduce sedentary behavior, which are important for improving overall health and quality of life. Additionally, online walking programs have been shown to improve physical fitness, blood pressure, and mental health in cancer survivors.12345
Is the Health Program for Breast Cancer Survivors safe for participants?
How does this treatment for breast cancer survivors differ from other treatments?
This treatment is unique because it uses wearable technology, like the Garmin Vivofit 2 activity monitor, combined with health coaching to encourage breast cancer survivors to be more active and reduce sitting time, which is different from traditional treatments that may not focus on lifestyle changes.235910
Research Team
Alexis Beatty, MD, MAS
Principal Investigator
University of California, San Francisco
Eligibility Criteria
This trial is for breast cancer survivors over 18 who can communicate in English, Spanish, or Cantonese. Participants must have been treated with the intent to cure at Zuckerberg San Francisco General Hospital and not be planning further chemotherapy, radiation, or surgery within the next three months.Inclusion Criteria
Exclusion Criteria
Timeline
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive a 12-week multi-disciplinary health behavior program with individualized assessments and plans
Follow-up
Participants are monitored for changes in health outcomes at 3, 6, and 12 months
Treatment Details
Interventions
- HEART-ACT
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of California, San Francisco
Lead Sponsor